Lonza Group AG
Lonza Bioscience Solutions provides life science researchers with the tools they need to develop and test critical drugs and therapies, from basic research to final product release.
KromaTiD, Inc.
KromaTiD uses single-cell, hybridization-based analysis to help gene and cell therapy developers bolster safety data for both research and regulatory filings.
ICON
ICON is a global provider of consulting, and outsourced development and commercialisation services to pharmaceutical, biotechnology, medical device and government and public health organisations. We focus our innovation on the factors that are critical to our clients - reducing time to market, reducing cost and increasing quality.